Latest Industry Updates
From company milestones to industry breakthroughs, uncover the stories making waves and shaping the narrative in real time.
- Press Release
CluePoints furthers its commitment to delivering innovative solutions that enhance clinical trial efficiency with this latest...
- Featured Article
As an industry, we regularly discuss the benefits of adopting risk-based quality management (RBQM). The good...
Source: International Clinical Trials/European Pharmaceutical Contractors
- Featured Article
François Torche dispels the myth that, at least in RBQM, there is such a thing as...
Source: PM360
- Featured Article
An increase in clinical trial data is driving demand for enhanced clinical trial processes. Sponsors want...
Source: Journal for Clinical Studies
- Featured Article
Artificial intelligence (AI) is a hot topic in pharma with myriad uses such as supporting clinical...
Source: Outsourcing Pharma
- Featured Article
With increasing pressure to overcome drug development challenges and advance drugs to market faster and with...
Source: Contract Pharma
- Featured Article
Today’s drug development landscape demands contract research organizations (CROs) provide flexible models that leverage the latest...
Source: Contract Pharma
- Featured Article
In an interview with ACT editor Andy Studna at DIA 2024, Hughes, co-founder and chief commercial...
Source: Applied Clinical Trials
- Press Release
Site Profile & Oversight Tool (SPOT) and Intelligent Medical Coding (IMC) unveiled by RBQM innovator at...
- Featured Article
Over the past 10 years we have seen a lot of progress in risk-based quality management...
Source: ACRP
- Press Release
CluePoints is a cloud-based software platform for Risk-Based Quality Management (“RBQM”) and data quality oversight in...
- Press Release
KING OF PRUSSIA, Pa., — CluePoints, provider of leading statistical and AI-driven software solutions, today unveiled...
- Press Release
Wayne, PA – October 02, 2018: CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Data...
- Press Release
Quanticate, a data-focused clinical research organisation (CRO), has announced that it has partnered with CluePoints to...
- Press Release
Since the initial publication of the ICH GCP guidelines, the way clinical trials operate has changed...
- Press Release
It appears that 2018 is the year CluePoints really established itself as a leader in the...
- Press Release
Successful pilot project prompts strategic partnership that strengthens risk-based monitoring in Japan and places both companies...
- Press Release
Wayne, PA – CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions...
- Press Release
Wayne, PA – CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions...
- Press Release
Wayne, PA – CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions...
- Press Release
Wayne, PA – CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions...
- Press Release
We’re delighted to announce that we’ll be at Partnerships in Clinical Trials next month! You can...
- Press Release
Today, we’re excited to announce that we’ve added an abundance of new features to the CluePoints...
- Press Release
This month, experts from across the globe will gather for CBI’s Global Risk-Based Monitoring event, taking...
- Featured Article
Despite the push for greater use of risk-based quality management (RBQM) in clinical research, adoption of...
Source: CenterWatch
- Featured Article
Central monitoring aims to detect emerging quality-related risks proactively during a clinical trial, resulting in study...
Source: Applied Clinical Trials
- Featured Article
CluePoints is continuing to invest in artificial intelligence (AI) and machine learning (ML) they say they...
Source: Outsourcing Pharma
- Featured Article
With the clinical trial landscape continuing to evolve and adapt, OSP took the opportunity to speak...
Source: Outsourcing Pharma
- Featured Article
Using key risk indicators (KRIs) can improve clinical trial data quality in 80% of the sites...
Source: Applied Clinical Trials
- Featured Article
Since the release of ICH E6(R2), multiple efforts have been made to interpret the requirements and...
- Read
Source: Springer Link
- Featured Article
An expectation for the use of quality tolerance limits (QTLs) was formally established in the International...
Source: Applied Clinical Trials
- Featured Article
Clinical research is evolving rapidly, with the digitalization of trials creating a new modus operandi and...
Source: Applied Clinical Trials
- Featured Article
Risk-based approaches to monitoring clinical trials were brought to the forefront with an FDA guidance published...
Source: Applied Clinical Trials
- Featured Article
Key risk indicators (KRIs) are metrics designed to identify risks of specific interest to study teams...
Source: Applied Clinical Trials
- Featured Article
The success of clinical development programmes, drug approval and marketing depends ultimately on the readability and...
Source: International Clinical Trials
- Featured Article
Central monitoring, which typically includes the use of key risk indicators (KRIs), aims at improving the...
Source: Springer Link